National Psoriasis Foundation Mobilizes Over $1.6 Million in Nationwide Fight Against Psoriatic Disease
May 19, 2026, 9:38 pm
Location: Egypt, Alexandria Governorate, Alexandria
Total raised: $1.24M
The National Psoriasis Foundation (NPF) recently concluded a pivotal series of national fundraising events. Soirées in Dallas and New York, alongside the Commit to Cure Gala in Salt Lake City, collectively amassed over $1.6 million. These significant funds directly propel critical research initiatives. They target breakthroughs for psoriatic disease. Millions of Americans live with psoriasis and psoriatic arthritis, a chronic immune-mediated condition. The NPF specifically leverages these contributions to advance advocacy efforts, develop earlier diagnostic tools, expand vital treatment options, and pursue an ultimate cure. Each successful event honored key leaders and dedicated partners, underscoring community power. This nationwide momentum strengthens the fight for improved lives, forging a future free from psoriatic disease burdens.
The National Psoriasis Foundation (NPF) recently demonstrated its formidable power. A series of impactful fundraising events swept the nation. From Dallas to New York, then to Salt Lake City, a collective spirit ignited. These galas mobilized substantial resources. Over $1.6 million poured in. This vital funding directly targets psoriatic disease. It promises accelerated research and robust advocacy. Millions of Americans struggle with this chronic condition. The NPF stands as their champion.
Psoriatic disease encompasses psoriasis and psoriatic arthritis. It affects over eight million individuals in the United States. This immune-mediated disease can be debilitating. It impacts skin, joints, and overall quality of life. The need for better treatments and a cure is urgent. The NPF's mission drives this critical work. It aims to improve lives and ultimately eradicate the disease.
The fundraising effort kicked off in Salt Lake City. The annual Commit to Cure Gala convened on April 11, 2026. This premier event drew more than 325 supporters. Healthcare leaders and industry partners joined forces. The Grand America Hotel hosted the inspiring evening. It proved immensely successful. The gala alone raised over $1,000,000. This single event represented a powerful commitment.
Leaders in the community received well-deserved recognition. Dr. Kristina Callis Duffin earned the Lifetime Achievement Award. Dr. Clive M. Liu, Dr. Catherine Bakewell, and Dr. Jessica Walsh each received Excellence in Leadership Awards. Their dedication fuels NPF's progress. Major sponsors made this success possible. Johnson & Johnson served as Presenting Sponsor. AbbVie and UCB were Diamond Sponsors. Lilly acted as a Sapphire Sponsor. Amgen contributed as an Emerald Sponsor. These partnerships are crucial.
Next, the New York Soirée gathered momentum. Held on April 16, 2026, at SECOND, it attracted over 225 attendees. This event reinforced the community's passion. Nearly $500,000 was raised. These funds further empower NPF's mission. They support groundbreaking research. They expand educational resources. They ensure access to critical patient support.
The New York event also celebrated outstanding leaders. Matthew Kiselica received the Excellence in Leadership & Volunteerism Award. Dr. James Krueger, PhD, earned the Lifetime Achievement Award. Their unwavering commitment shines brightly. Generous sponsors backed this vital effort. Johnson & Johnson was the Presenting Sponsor. Lilly joined as Cures Sponsor. Novartis, NYU Langone Health, and Organon provided Progress Sponsorships. Collaboration drives innovation.
Finally, the Dallas Soirée concluded the powerful series. It took place on April 25, 2026. The Fairmont Dallas hosted over 175 advocates and supporters. The evening focused on celebrating women in leadership. It raised nearly $150,000. These contributions directly aid NPF's initiatives. They support developing earlier diagnostic tools. They advance treatment options. They push closer to a cure for psoriatic arthritis and psoriasis.
Dallas honored exceptional women. Dr. Jennifer Cather received a Women in Leadership Award. Melodie Young, MSN, A/GNP-C, also earned this prestigious recognition. Their expertise and compassion inspire many. Johnson & Johnson served as Presenting Sponsor. Organon was a key Progress Sponsor. These corporate partnerships demonstrate strong commitment to public health.
The collective impact of these events is profound. Over $1.6 million is now earmarked for the fight against psoriatic disease. These funds will accelerate scientific discovery. They will translate into better patient outcomes. Research initiatives will explore new pathways. They will identify novel therapeutic targets. Early diagnosis of psoriatic arthritis is a key focus. This prevents irreversible joint damage.
Advocacy efforts will also intensify. The NPF champions policies that benefit patients. It works to ensure access to care and treatment. It educates the public about psoriatic disease. Stigma reduction remains a priority. Educational resources reach families nationwide. This empowers individuals with knowledge. It fosters informed self-management.
The events underscored the power of community. Individuals, healthcare professionals, and corporations united. Their shared dedication is undeniable. This national collaboration strengthens the NPF's reach. It magnifies its influence. Every dollar raised represents hope. It signifies progress for millions.
The National Psoriasis Foundation continues its relentless pursuit. A future free from psoriatic disease burdens is the ultimate goal. The recent national fundraising series brought this vision closer. It highlighted sustained commitment. It showcased powerful partnerships. The NPF's work is far from over. Yet, these successes provide immense momentum. They fuel optimism. They promise a healthier tomorrow for all affected by psoriatic disease.
The National Psoriasis Foundation (NPF) recently demonstrated its formidable power. A series of impactful fundraising events swept the nation. From Dallas to New York, then to Salt Lake City, a collective spirit ignited. These galas mobilized substantial resources. Over $1.6 million poured in. This vital funding directly targets psoriatic disease. It promises accelerated research and robust advocacy. Millions of Americans struggle with this chronic condition. The NPF stands as their champion.
Psoriatic disease encompasses psoriasis and psoriatic arthritis. It affects over eight million individuals in the United States. This immune-mediated disease can be debilitating. It impacts skin, joints, and overall quality of life. The need for better treatments and a cure is urgent. The NPF's mission drives this critical work. It aims to improve lives and ultimately eradicate the disease.
The fundraising effort kicked off in Salt Lake City. The annual Commit to Cure Gala convened on April 11, 2026. This premier event drew more than 325 supporters. Healthcare leaders and industry partners joined forces. The Grand America Hotel hosted the inspiring evening. It proved immensely successful. The gala alone raised over $1,000,000. This single event represented a powerful commitment.
Leaders in the community received well-deserved recognition. Dr. Kristina Callis Duffin earned the Lifetime Achievement Award. Dr. Clive M. Liu, Dr. Catherine Bakewell, and Dr. Jessica Walsh each received Excellence in Leadership Awards. Their dedication fuels NPF's progress. Major sponsors made this success possible. Johnson & Johnson served as Presenting Sponsor. AbbVie and UCB were Diamond Sponsors. Lilly acted as a Sapphire Sponsor. Amgen contributed as an Emerald Sponsor. These partnerships are crucial.
Next, the New York Soirée gathered momentum. Held on April 16, 2026, at SECOND, it attracted over 225 attendees. This event reinforced the community's passion. Nearly $500,000 was raised. These funds further empower NPF's mission. They support groundbreaking research. They expand educational resources. They ensure access to critical patient support.
The New York event also celebrated outstanding leaders. Matthew Kiselica received the Excellence in Leadership & Volunteerism Award. Dr. James Krueger, PhD, earned the Lifetime Achievement Award. Their unwavering commitment shines brightly. Generous sponsors backed this vital effort. Johnson & Johnson was the Presenting Sponsor. Lilly joined as Cures Sponsor. Novartis, NYU Langone Health, and Organon provided Progress Sponsorships. Collaboration drives innovation.
Finally, the Dallas Soirée concluded the powerful series. It took place on April 25, 2026. The Fairmont Dallas hosted over 175 advocates and supporters. The evening focused on celebrating women in leadership. It raised nearly $150,000. These contributions directly aid NPF's initiatives. They support developing earlier diagnostic tools. They advance treatment options. They push closer to a cure for psoriatic arthritis and psoriasis.
Dallas honored exceptional women. Dr. Jennifer Cather received a Women in Leadership Award. Melodie Young, MSN, A/GNP-C, also earned this prestigious recognition. Their expertise and compassion inspire many. Johnson & Johnson served as Presenting Sponsor. Organon was a key Progress Sponsor. These corporate partnerships demonstrate strong commitment to public health.
The collective impact of these events is profound. Over $1.6 million is now earmarked for the fight against psoriatic disease. These funds will accelerate scientific discovery. They will translate into better patient outcomes. Research initiatives will explore new pathways. They will identify novel therapeutic targets. Early diagnosis of psoriatic arthritis is a key focus. This prevents irreversible joint damage.
Advocacy efforts will also intensify. The NPF champions policies that benefit patients. It works to ensure access to care and treatment. It educates the public about psoriatic disease. Stigma reduction remains a priority. Educational resources reach families nationwide. This empowers individuals with knowledge. It fosters informed self-management.
The events underscored the power of community. Individuals, healthcare professionals, and corporations united. Their shared dedication is undeniable. This national collaboration strengthens the NPF's reach. It magnifies its influence. Every dollar raised represents hope. It signifies progress for millions.
The National Psoriasis Foundation continues its relentless pursuit. A future free from psoriatic disease burdens is the ultimate goal. The recent national fundraising series brought this vision closer. It highlighted sustained commitment. It showcased powerful partnerships. The NPF's work is far from over. Yet, these successes provide immense momentum. They fuel optimism. They promise a healthier tomorrow for all affected by psoriatic disease.